Sponsor

Shenzhen Hank Bioengineering Institute

Clinical research sponsor

Published trials5

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

5 shown

High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung CancerNCT03007875 · collaborator · 2016-12-01

COMPLETED

Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast CancerNCT02843126 · collaborator · 2016-07-01

COMPLETED

Combination of Cryosurgery and NK Immunotherapy for Advanced Breast CancerNCT02844335 · collaborator · 2016-07-01

COMPLETED

Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung CancerNCT02843815 · collaborator · 2016-07-01

COMPLETED

Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung CancerNCT02845856 · collaborator · 2016-07-01

COMPLETED

Sponsor roles

collaborator5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.